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LETTERS
HIV/AIDS IN PUERTO RICAN
PEOPLE WHO INJECT DRUGS:
POLICY CONSIDERATIONS
We commend the important work of Deren
et al.1 that underscores the high rates of HIV
among Puerto Rican people who inject drugs
(PRPWID) and highlights the health, social, and
service disparities between Puerto Rico and the
Northeast US region. As articulated in their
article, HIV/AIDS risk and substance use are
not individual problems with individual
consequences—the epidemic impacts community
and culture, across borders and boundaries. In
addition to service disparities, various socio-
economic contextual factors are associated with
and may exacerbate the spread of HIV/AIDS in
PRPWID, including limited educational and
employment opportunities, poverty, and polit-
ical disenfranchisement. Efforts to reduce the
incidence of HIV/AIDS and associated health
risks and complications, including other infec-
tions, drug overdose, and social stigma, neces-
sitate structural policy intervention in addition
to programmatic improvements. Moreover,
policy implementation that attends to contex-
tual factors such as incarceration and impedi-
ments to culturally appropriate services is
needed. We identify two contexts that repre-
sent opportunities for improvements in policy
implementation that may curb the HIV/AIDS
epidemic among PRPWID.
First, the federal ban on funding for syringe
exchange programming undermines the public
health mission of limiting the spread of blood-
borne pathogens. Although President Obama
signed a law to lift this ban in 2009, Congress
restored it in 2012. Reallocating federal fund-
ing to syringe exchange programming may
be an effective way to reduce the spread of
HIV/AIDS in PRPWID.
Second, the United States has the highest
documented incarceration rate in the world,
with more than 1.5 million people imprisoned
on nonviolent drug charges in 2013.2 The
federal budget for drug prevention has de-
creased steadily since 2004, whereas funding
for law enforcement and incarceration has
increased.3 Although White House Principles
of Modern Drug Policy mandate that drug-
involved individuals in the criminal justice
system be supervised with respect for their
basic human rights and provided with sub-
stance use treatment, access to these services
is limited. The criminal justice system has the
potential to play a vital role in breaking the
cycle of drug use, crime, incarceration, and
rearrest by providing more treatment in cor-
rectional facilities and alternatives to incarcer-
ation (e.g., drug courts). Resources allocated to
drug prevention during reentry may be a viable
solution to reducing drug relapse and contain-
ing the HIV/AIDS epidemic. Equitable avail-
ability and effective implementation of these
federal policies, in both Puerto Rico and the US
mainland, may contribute to reduce the dis-
proportionate amount of PRPWID with HIV/
AIDS and bring much needed services to this
population. j
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DEREN ET AL. RESPOND
We agree with the recommendations made
by Lopez et al. to address contextual factors
influencing the high rates of HIV among Puerto
Rican people who inject drugs (PRPWID). We
note that a recent publication from the Centers
for Disease Control and Prevention (CDC),
published after completion of our original
article, described progress along the continuum
of HIV care for Hispanics,1 identifying the
ongoing health disparities among people who
inject drugs (PWID). The CDC report found
that among those Hispanics who were HIV-
infected, linkage to care and viral suppression
were lower among those whose HIV infection
was attributed to injection drug use than
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among those with infection attributed to other
risk factors. As shown in our previous article,
Puerto Ricans are overrepresented among
Hispanic PWID. This further supports the need
for coordinated public health efforts to target
this vulnerable population to reduce HIV in-
fection (e.g., enhanced access to clean syringes
and to drug abuse treatment) and to address
disparities along the HIV care continuum.
It is important to note that many of the
strategies that can reduce HIV-related health
disparities among PRPWID (e.g., expanded
drug abuse treatment and syringe exchange
programs and engagement in available phar-
maceutical treatments) are also needed to
control the disproportionally high rates of
hepatitis C found among PRPWID. HCV prev-
alence among PRPWID in Puerto Rico ap-
proaches 90%2 and greatly contributes to the
higher prevalence of HCV found among adults
in Puerto Rico compared with the mainland
United States.3 Furthermore, studies in New
York City found that HCV infection rates
among PWID were higher among PRPWID
compared with other PWID4 and were partic-
ularly high among those who came from Puerto
Rico (85%, compared with 58% for non-
Hispanics and 62% for US-born Puerto Ricans;
C. G. A., unpublished data, 2014). New HCV
treatments that can result in cure5 can further
reduce health disparities experienced by
PRPWID, and have been shown to be cost-
effective.6 The tools to reduce the HIV- and
HCV-related health disparities for PRPWID are
available, but efforts to harness these tools
are needed to bring their promise to fulfillment.
As recommended in our earlier article with
respect to HIV, multiregion coordinated efforts
can also be used to address the high rates of
HCV among PRPWID. j
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